MurrayMBernMD

PubMed

• 16 citations
  Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.
  Murray M. Bern> ;Clinical and Translational Medicine. 2017 Sep 21
• 10 citations
  Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospe...
  Murray M. Bern, Diane Hazel, Elizabeth Deeran, John R. Richmond, Daniel M Ward, Damon J. Spitz, David A. Mattingly, James V. Bono, Ronna H. Berezin, Laura Hou, Gerald ...> ;Thrombosis Journal. 2015 Oct 7
• 5 citations
  Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease.
  Murray M. Bern, Nancy McCarthy> ;Blood Coagulation & Fibrinolysis. 2013 Jan 1
• 9 citations
  Failure to Lyse Venous Thrombi Because of Elevated Plasminogen Activator Inhibitor 1 (PAI-1) and 4G Polymorphism of Its Promotor Genome (The PAI-1/4G Syndrome)
  Murray M. Bern, Nancy McCarthy> ;Clinical and Applied Thrombosis/hemostasis. 2010 Aug 19
• 14 citations
  Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty
  Murray M. Bern, Rahul V. Deshmukh, Russell Nelson, Benjamin E. Bierbaum, Nancy Sevier, Noreen Howie, Elena Losina, Jeffrey N. Katz> ;The Journal of Arthroplasty. 2007 Aug 1
• 12 citations
  Clinically significant pseudohyponatremia
  Murray M. Bern> ;American Journal of Hematology. 2006 Jul 1
• 14 citations
  Coagulopathy, following medical therapy, for carcinoma of the prostate
  Murray M. Bern> ;Hematology. 2005 Feb 1
• 6 citations
  Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
  Murray M. Bern> ;JPEN. Journal of Parenteral and Enteral Nutrition. 2004 Nov 1
• 7 citations
  Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement.
  Murray M. Bern, Benjamin E. Bierbaum, Steven M. Wetzner, William Brennan, Sheila McAlister> ;American Journal of Hematology. 2002 Oct 1
• 30 citations
  Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.
  Jacob J. Lokich, Henry Sonneborn, Norwood R. Anderson, Murray M. Bern, Frank V. Coco, Edward Dow, Peter Oliynyk> ;Cancer. 1999 Jun 1
• 14 citations
  The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.
  Jacob J. Lokich, Norwood Anderson, Murray M. Bern, Frank Coco, Edward Dow> ;Cancer. 1999 Jan 15
• 6 citations
  A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluo...
  Norwood Anderson, Jacob J. Lokich, Cherie Moore, Murray M. Bern, Frank Coco> ;Cancer Investigation. 1999 Jan 1
• 10 citations
  Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer
  J. Lokich, N Anderson, M Bern, F Coco, S Gotthardt, P Oliynyk, E Dow> ;European Journal of Cancer. 1998 Apr 1
• 11 citations
  Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas
  J. Lokich, N Anderson, C Moore, M Bern, F Coco, H Sonneborn, E Dow, D Strong> ;European Journal of Cancer. 1998 Apr 1
• 2 citations
  Phase I–II trial of 14 day infusional 6-Mercaptopurine in advanced colorectal cancer
  J. Lokich, C Moore, N Anderson, M Bern, F Coco, E Dow, T. Zipoli> ;European Journal of Cancer. 1998 Mar 1
• 2 citations
  Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
  J. Lokich, N Anderson, Moore C, Murray M. Bern, F Coco, E Dow, T. Zipoli, L. Gonzalves> ;The Journal of Infusional Chemotherapy. 1996 Jan 1
• Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
  J. Lokich, N Anderson, Moore C, Murray M. Bern, F Coco, E Dow> ;The Journal of Infusional Chemotherapy. 1996 Jan 1
• 5 citations
  Multi-day fractionated administration schedule for paclitaxel
  J. Lokich, N Anderson, Murray M. Bern, F Coco, E Dow, Moore C, T. Zipoli, L. Gonzalves> ;Annals of Oncology. 1995 Nov 1
• 1 citations
  Pilot study of ambulatory infusional ifosfamide admixed with carboplatin
  Jacob J. Lokich, Zipoli T, Norwood Anderson, Cherie Moore, Leslie Gonzalves, Murray M. Bern, Frank Coco> ;Cancer. 1993 Mar 15
• 2 citations
  Considerations for using lower doses of warfarin.
  Murray M. Bern> ;Hematology/oncology Clinics of North America. 1992 Oct 1
• 2 citations
  Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.
  Jacob J. Lokich, N Anderson, Murray M. Bern, Zipoli T, L. Gonsalves, Moore C> ;American Journal of Clinical Oncology. 1992 Aug 1
• 3 citations
  Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
  J. Lokich, C Moore, N Anderson, M Bern> ;European Journal of Cancer. 1991 Dec 1
• 11 citations
  Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.
  J. Lokich, N. Anderson, Murray M. Bern, F Coco, T. Zipoli, Moore C, L. Gonsalves> ;Cancer. 1991 Aug 15
• 6 citations
  Infusional carboplatin. Phase I studies of 5-day and 14-day infusions.
  J. Lokich, N. Anderson, Murray M. Bern, T. Zipli, L. Gonsalves, Cherie Moore> ;Cancer. 1991 Jul 1
• 13 citations
  Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle.
  J. Lokich, N. Anderson, Murray M. Bern, Cherie Moore> ;Cancer. 1991 Feb 15
• Join now to see all